1. Home
  2. IBEX vs ACIU Comparison

IBEX vs ACIU Comparison

Compare IBEX & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBEX
    SELLHOLDBUYas of 7 hours ago
  • ACIU
    SELLHOLDBUYas of 7 hours ago
  • Stock Information
  • Founded
  • IBEX 2017
  • ACIU 2003
  • Country
  • IBEX United States
  • ACIU Switzerland
  • Employees
  • IBEX N/A
  • ACIU N/A
  • Industry
  • IBEX EDP Services
  • ACIU Biotechnology: Pharmaceutical Preparations
  • Sector
  • IBEX Technology
  • ACIU Health Care
  • Exchange
  • IBEX Nasdaq
  • ACIU Nasdaq
  • Market Cap
  • IBEX 267.7M
  • ACIU 247.4M
  • IPO Year
  • IBEX 2020
  • ACIU 2016
  • Fundamental
  • Price
  • IBEX $24.98
  • ACIU $1.88
  • Analyst Decision
  • IBEX Buy
  • ACIU Strong Buy
  • Analyst Count
  • IBEX 2
  • ACIU 2
  • Target Price
  • IBEX $25.00
  • ACIU $12.00
  • AVG Volume (30 Days)
  • IBEX 183.9K
  • ACIU 187.3K
  • Earning Date
  • IBEX 05-08-2025
  • ACIU 03-13-2025
  • Dividend Yield
  • IBEX N/A
  • ACIU N/A
  • EPS Growth
  • IBEX 37.48
  • ACIU N/A
  • EPS
  • IBEX 2.13
  • ACIU N/A
  • Revenue
  • IBEX $521,725,000.00
  • ACIU $30,136,397.00
  • Revenue This Year
  • IBEX $6.47
  • ACIU $120.91
  • Revenue Next Year
  • IBEX $4.29
  • ACIU $13.82
  • P/E Ratio
  • IBEX $11.79
  • ACIU N/A
  • Revenue Growth
  • IBEX 1.66
  • ACIU 84.51
  • 52 Week Low
  • IBEX $13.00
  • ACIU $1.77
  • 52 Week High
  • IBEX $27.83
  • ACIU $4.98
  • Technical
  • Relative Strength Index (RSI)
  • IBEX 50.72
  • ACIU 29.21
  • Support Level
  • IBEX $22.50
  • ACIU $1.77
  • Resistance Level
  • IBEX $25.16
  • ACIU $2.05
  • Average True Range (ATR)
  • IBEX 1.07
  • ACIU 0.12
  • MACD
  • IBEX -0.09
  • ACIU -0.02
  • Stochastic Oscillator
  • IBEX 58.22
  • ACIU 18.71

Stock Price Comparison Chart: IBEX vs ACIU

IBEX
ACIU
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April024681012141618202224262830IBEX VS ACIU

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use